✦ LIBER ✦

A phase 3, randomized, double-blinded, active-controlled, unblinded standard of care study assessing the efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory angina: Design of the RENEW study

✍ Scribed by Povsic, Thomas J.; Junge, Candice; Nada, Adel; Schatz, Richard A.; Harrington, Robert A.; Davidson, Charles J.; Fortuin, F. David; Kereiakes, Dean J.; Mendelsohn, Farrell O.; Sherman, Warren; Schaer, Gary L.; White, Christopher J.; Stewart, Duncan; Story, Kenneth; Losordo, Douglas W.; Henry, Timothy D.

Book ID: 122774989
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 864 KB
Volume: 165
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2013.03.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II, sham-controlled, double-blin

A phase II, sham-controlled, double-blinded study testing the safety and efficacy of the coronary sinus reducer in patients with refractory angina: study protocol for a randomized controlled trial

✍ E Marc Jolicœur, Shmuel Banai, Timothy D Henry, Marc Schwartz, Serge Doucet… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 420 KB

A randomized, partially blinded, multice

A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: Design and rationale of the RADAR Phase IIb trial

✍ Thomas J. Povsic; Mauricio G. Cohen; Roxana Mehran; Christopher E. Buller; Chris 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 448 KB

A Phase III, Randomized, Double-blind, P

A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess the Efficacy and Safety of the β3 Adrenoceptor Agonist, Mirabegron, in Patients With Symptoms of Overactive Bladder

✍ Herschorn, Sender; Barkin, Jack; Castro-Diaz, David; Frankel, Jeffrey M.; Espuna 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 407 KB

943d A Phase 2/3 Randomized, Placebo-con

943d A Phase 2/3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Subcutaneous Golimumab Induction Therapy in Patients with Moderately to Severely Active Ulcerative Colitis: PURSUIT SC

✍ W.J. Sandborn; B.G. Feagan; C.W. Marano; R. Strauss; J. Johanns; H. Zhang; J. Co 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Comparison of the clinical efficacy and

Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: Results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial

✍ J. Braun; P. Kästner; P. Flaxenberg; J. Währisch; P. Hanke; W. Demary; U. von Hi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB 👁 3 views

Rationale and design of the EMBRACE STEM

Rationale and design of the EMBRACE STEMI Study: A phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction

✍ Chakrabarti, Anjan K.; Feeney, Kristin; Abueg, Cassandra; Brown, David A.; Czyz, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 322 KB